Victory Capital Management’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-1,625
| Closed | -$4K | – | 2792 |
|
2022
Q1 | $4K | Buy |
1,625
+138
| +9% | +$340 | ﹤0.01% | 2716 |
|
2021
Q4 | $8K | Buy |
1,487
+28
| +2% | +$151 | ﹤0.01% | 2742 |
|
2021
Q3 | $16K | Buy |
1,459
+94
| +7% | +$1.03K | ﹤0.01% | 2740 |
|
2021
Q2 | $23K | Buy |
1,365
+333
| +32% | +$5.61K | ﹤0.01% | 2704 |
|
2021
Q1 | $27K | Buy |
1,032
+178
| +21% | +$4.66K | ﹤0.01% | 2706 |
|
2020
Q4 | $31K | Buy |
854
+96
| +13% | +$3.49K | ﹤0.01% | 2484 |
|
2020
Q3 | $27K | Sell |
758
-14
| -2% | -$499 | ﹤0.01% | 2418 |
|
2020
Q2 | $33K | Buy |
772
+210
| +37% | +$8.98K | ﹤0.01% | 2420 |
|
2020
Q1 | $44K | Buy |
+562
| New | +$44K | ﹤0.01% | 2833 |
|
2019
Q4 | – | Sell |
-441
| Closed | -$33K | – | 3552 |
|
2019
Q3 | $33K | Buy |
+441
| New | +$33K | ﹤0.01% | 2873 |
|